Acerta Pharma serves as AstraZeneca’s “Hematologic Oncology Center of Excellence”. As such, it has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced compounds for hematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer.
View Top Employees from Acerta Pharma (A member of the AstraZeneca Group)Website | http://www.acerta-pharma.com/ |
Revenue | $41 million |
Employees | 165 (165 on RocketReach) |
Founded | 2013 |
Address | Kloosterstraat 9, Oss, North Brabant 94080, NL |
Phone | +31 412 700 574 |
Technologies |
JavaScript,
HTML,
Amazon CloudFront
+14 more
(view full list)
|
Industry | Pharmaceuticals, Manufacturing General, Drug Discovery, Manufacturing, Laboratory Services (Healthcare) |
Web Rank | 7 Million |
Keywords | Acerta Pharma Vacatures, Acerta, Acerta Pharma, Acalabrutinib, Cll Sll Btk Pathway |
Competitors | Acadia Pharmaceuticals Inc., Incyte, Nimbus Therapeutics, Pharmacyclics, an AbbVie Company, Translational Drug Development (TD2) |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies, NAICS Code 325 Companies |
Looking for a particular Acerta Pharma (A member of the AstraZeneca Group) employee's phone or email?
The Acerta Pharma (A member of the AstraZeneca Group) annual revenue was $41 million in 2024.
Nico Stam is the Executive Board Member of Acerta Pharma (A member of the AstraZeneca Group).
165 people are employed at Acerta Pharma (A member of the AstraZeneca Group).
Acerta Pharma (A member of the AstraZeneca Group) is based in Oss, North Brabant.
The NAICS codes for Acerta Pharma (A member of the AstraZeneca Group) are [32541, 32, 3254, 325].
The SIC codes for Acerta Pharma (A member of the AstraZeneca Group) are [283, 28].